Journal
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 323, Issue 1, Pages E2-E7Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00441.2021
Keywords
diabetes; hyperinsulinemia; insulin clearance; insulin secretion profile; obesity
Categories
Funding
- National Institute for Dementia Research Grant [APP1113494]
Ask authors/readers for more resources
This review discusses the causes, pathophysiology, and metabolic consequences of hyperinsulinemia, as well as current treatment options.
Insulin, a principal anabolic hormone produced by pancreatic beta-cells, has a primary function of storage of nutrients following excessive energy intake. Pre- or early type 2 diabetes stages present hyperinsulinemia (beta-cell dysfunction) and insulin resistance. Initiation of hyperinsulinemia is triggered by a loss of first-phase glucose-stimulated insulin secretion with altered membrane ion channel distribution. More factors, including insulin resistance and excessive proliferation of a-cells, deteriorate the hyperinsulinemia, whereas the hyperinsulinemia contributes to further development of insulin resistance and type 2 diabetes; to develop eventually late-stage diabetes with absolute insulin deficiency. In this mini-review, the major focus was put on the causes and pathophysiology of hyperinsulinemia, and the metabolic consequences and current treatment of hyperinsulinemia were discussed. The data used in this narrative review were collected mainly from relevant discoveries in the past 3 years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available